Aakaar Medical Technologies Ltd. (NSE:AAKAAR)
India · Delayed Price · Currency is INR 65.00
-0.95 (-1.44%)
At close: Oct 1, 2026
NSE:AAKAAR Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 669.64 | 615.83 | 461.11 | 327.85 | 194.65 |
| 669.64 | 615.83 | 461.11 | 327.85 | 194.65 | |
Revenue Growth | 8.74% | 33.55% | 40.65% | 68.42% | 56.50% |
Cost of Revenue | 282.49 | 262.68 | 210.07 | 150.08 | 91.04 |
Gross Profit | 387.15 | 353.15 | 251.04 | 177.77 | 103.61 |
Selling, General & Admin | 173.93 | 162.76 | 128.69 | 77.28 | 39.76 |
Other Operating Expenses | 110.01 | 92.39 | 71.53 | 63.44 | 39.18 |
Operating Expenses | 285.22 | 256.4 | 201.57 | 141.62 | 79.16 |
Operating Income | 101.93 | 96.75 | 49.47 | 36.15 | 24.45 |
Interest Expense | -16.55 | -15.77 | -9.91 | -3.61 | -0.3 |
Interest & Investment Income | 7.8 | 0.13 | 0.16 | 0.12 | 0.16 |
Currency Exchange Gain (Loss) | 0.15 | 1.35 | 0.6 | -0.8 | 0.2 |
Other Non Operating Income (Expenses) | -1.42 | -1.32 | -1.46 | -0.7 | 0 |
EBT Excluding Unusual Items | 91.92 | 81.14 | 38.85 | 31.17 | 24.51 |
Asset Writedown | - | - | - | -0.14 | - |
Pretax Income | 91.92 | 81.14 | 38.85 | 31.03 | 24.51 |
Income Tax Expense | 25.54 | 20.81 | 10.15 | 9.49 | 6.52 |
Net Income | 66.38 | 60.33 | 28.7 | 21.53 | 18 |
Net Income to Common | 66.38 | 60.33 | 28.7 | 21.53 | 18 |
Net Income Growth | 10.03% | 110.18% | 33.30% | 19.65% | 230.59% |
Shares Outstanding (Basic) | 13 | 10 | 9 | 9 | 9 |
Shares Outstanding (Diluted) | 13 | 10 | 9 | 9 | 9 |
Shares Change | 34.81% | 7.84% | 0.19% | 0.26% | - |
EPS (Basic) | 4.99 | 6.12 | 3.15 | 2.37 | 1.98 |
EPS (Diluted) | 4.99 | 6.12 | 3.14 | 2.36 | 1.98 |
EPS Growth | -18.46% | 94.90% | 33.05% | 19.34% | 230.59% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -89.4 | -54.9 | -80.96 | -31.91 | 1.11 |
Free Cash Flow Per Share | -6.73 | -5.57 | -8.86 | -3.50 | 0.12 |
Dividend Per Share | - | - | - | 0.577 | 0.615 |
Dividend Growth | - | - | - | -6.26% | - |
Gross Margin | 57.81% | 57.34% | 54.44% | 54.22% | 53.23% |
Operating Margin | 15.22% | 15.71% | 10.73% | 11.03% | 12.56% |
Profit Margin | 9.91% | 9.80% | 6.22% | 6.57% | 9.25% |
Free Cash Flow Margin | -13.35% | -8.91% | -17.56% | -9.73% | 0.57% |
EBITDA | 103.21 | 98 | 50.82 | 37.05 | 24.67 |
EBITDA Margin | 15.41% | 15.91% | 11.02% | 11.30% | 12.67% |
D&A For EBITDA | 1.28 | 1.25 | 1.35 | 0.89 | 0.22 |
EBIT | 101.93 | 96.75 | 49.47 | 36.15 | 24.45 |
EBIT Margin | 15.22% | 15.71% | 10.73% | 11.03% | 12.56% |
Effective Tax Rate | 27.79% | 25.65% | 26.13% | 30.60% | 26.59% |
Revenue as Reported | 677.69 | 617.61 | 462.7 | 328.79 | 195.09 |
Advertising Expenses | 27.84 | 28.88 | 21.28 | 17.41 | - |